APTO

Aptose Biosciences Inc.

APTO | NASDAQ Capital Market

0.279USD0.1088 %

Analyze Aptose Biosciences Inc.'s free cash flow data, illustrating cash reserves post-capital expenditures and future projections.

Breakdown2028202720262025202420232022202120202019
Revenue
0
0
0
0
0
0
0
0
0
0
Ebitda
0
0
0
0
0
-52.27 M
%31.79
-39.66 M
%-38.19
-64.16 M
%11.57
-57.51 M
%119.00
-26.26 M
Ebit
0
0
0
0
0
-52.36 M
%30.35
-40.17 M
%-38.00
-64.78 M
%11.39
-58.16 M
%116.29
-26.89 M
Tax Rate
0
0
0
0
0
0
0
0
0
0
Ebiat
0
0
0
0
0
-52.36 M
%32.79
-39.43 M
%-39.05
-64.69 M
%12.31
-57.6 M
%119.05
-26.29 M
Depreciation
0
0
0
0
0
88 K
%-82.65
507.08 K
%-17.75
616.53 K
%-4.63
646.43 K
%3.06
627.25 K
Receivables
0
0
0
0
0
0
0
0
0
0
Inventories
0
0
0
0
0
0
0
0
0
0
Payable
0
0
0
0
0
6.05 M
%-4.43
6.33 M
%272.34
1.7 M
%-21.74
2.17 M
%10.77
1.96 M
Cap Ex
0
0
0
0
0
-29 K
%20.83
-24 K
%-88.68
-212 K
%168.35
-79 K
%-22.55
-102 K
Ufcf
0
0
0
0
-6.05 M
%-88.50
-52.58 M
%53.21
-34.32 M
%-47.01
-64.75 M
%13.96
-56.82 M
%138.65
-23.81 M
Wacc
8.54
%0.00
8.54
%0.00
8.54
%0.00
8.54
%0.00
8.54
%-0.12
8.55
%0.23
8.53
%-0.23
8.55
%0.12
8.54
%0.23
8.52